Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Other Accumulated Expenses (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Other Accumulated Expenses for 5 consecutive years, with $133000.0 as the latest value for Q2 2020.

  • On a quarterly basis, Other Accumulated Expenses fell 93.93% to $133000.0 in Q2 2020 year-over-year; TTM through Jun 2020 was $133000.0, a 93.93% decrease, with the full-year FY2019 number at $2000.0, down 99.88% from a year prior.
  • Other Accumulated Expenses was $133000.0 for Q2 2020 at Forte Biosciences, down from $344000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $2.2 million in Q2 2019 to a low of $2000.0 in Q4 2019.
  • A 5-year average of $1.0 million and a median of $844000.0 in 2017 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: soared 229.73% in 2018, then plummeted 99.88% in 2019.
  • Forte Biosciences' Other Accumulated Expenses stood at $312000.0 in 2016, then surged by 199.04% to $933000.0 in 2017, then skyrocketed by 74.6% to $1.6 million in 2018, then tumbled by 99.88% to $2000.0 in 2019, then skyrocketed by 6550.0% to $133000.0 in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Other Accumulated Expenses are $133000.0 (Q2 2020), $344000.0 (Q1 2020), and $2000.0 (Q4 2019).